Christopher Garabedian
Directeur/Membre du Conseil chez Quellis Biosciences LLC
Profil
Christopher Garabedian has held director positions at CereVasc, Inc. and Quellis Biosciences LLC.
Postes actifs de Christopher Garabedian
| Sociétés | Poste | Début |
|---|---|---|
Quellis Biosciences LLC
 Quellis Biosciences LLC Pharmaceuticals: MajorHealth Technology Quellis Biosciences, Inc. operates as a biotechnology company. The company is headquartered in Boston, MA. | Directeur/Membre du Conseil | - |
CereVasc, Inc.
 CereVasc, Inc. Medical SpecialtiesHealth Technology CereVasc, Inc. engages in healthcare services. Ito focuses on the development of novel, minimally invasive treatments for patients with neurological diseases. The company was founded by Dan Levangie, Patrick Sullivan, Carl Heilman, and Adel Malek and is headquartered in Auburndale, MA. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Quellis Biosciences LLC
Quellis Biosciences LLC Pharmaceuticals: MajorHealth Technology Quellis Biosciences, Inc. operates as a biotechnology company. The company is headquartered in Boston, MA. | Health Technology |
CereVasc, Inc.
CereVasc, Inc. Medical SpecialtiesHealth Technology CereVasc, Inc. engages in healthcare services. Ito focuses on the development of novel, minimally invasive treatments for patients with neurological diseases. The company was founded by Dan Levangie, Patrick Sullivan, Carl Heilman, and Adel Malek and is headquartered in Auburndale, MA. | Health Technology |